作者
Martin Wilson, Ovidiu Andronesi, Peter B Barker, Robert Bartha, Alberto Bizzi, Patrick J Bolan, Kevin M Brindle, In‐Young Choi, Cristina Cudalbu, Ulrike Dydak, Uzay E Emir, Ramon G Gonzalez, Stephan Gruber, Rolf Gruetter, Rakesh K Gupta, Arend Heerschap, Anke Henning, Hoby P Hetherington, Petra S Huppi, Ralph E Hurd, Kejal Kantarci, Risto A Kauppinen, Dennis WJ Klomp, Roland Kreis, Marijn J Kruiskamp, Martin O Leach, Alexander P Lin, Peter R Luijten, Małgorzata Marjańska, Andrew A Maudsley, Dieter J Meyerhoff, Carolyn E Mountford, Paul G Mullins, James B Murdoch, Sarah J Nelson, Ralph Noeske, Gülin Öz, Julie W Pan, Andrew C Peet, Harish Poptani, Stefan Posse, Eva‐Maria Ratai, Nouha Salibi, Tom WJ Scheenen, Ian CP Smith, Brian J Soher, Ivan Tkáč, Daniel B Vigneron, Franklyn A Howe
发表日期
2019/8
来源
Magnetic resonance in medicine
卷号
82
期号
2
页码范围
527-550
简介
Proton MRS (1H MRS) provides noninvasive, quantitative metabolite profiles of tissue and has been shown to aid the clinical management of several brain diseases. Although most modern clinical MR scanners support MRS capabilities, routine use is largely restricted to specialized centers with good access to MR research support. Widespread adoption has been slow for several reasons, and technical challenges toward obtaining reliable good‐quality results have been identified as a contributing factor. Considerable progress has been made by the research community to address many of these challenges, and in this paper a consensus is presented on deficiencies in widely available MRS methodology and validated improvements that are currently in routine use at several clinical research institutions. In particular, the localization error for the PRESS localization sequence was found to be unacceptably high at 3 …
学术搜索中的文章
M Wilson, O Andronesi, PB Barker, R Bartha, A Bizzi… - Magnetic resonance in medicine, 2019